Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Johnson and Johnson
Merck
AstraZeneca
McKinsey

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Litigation Details for SUNOVION PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2009)

See Plans and Pricing

« Back to Dashboard

SUNOVION PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2009)

Docket   Start Trial Date Filed 2009-03-20
Court District Court, D. New Jersey Date Terminated 2013-06-26
Cause 35:271 Patent Infringement Assigned To Susan Davis Wigenton
Jury Demand None Referred To Magistrate Judge Mark Falk
Parties ALPHAPHARM PTY. LTD.; COBALT LABORATORIES INC.; COBALT PHARMACEUTICALS INC.; DR. REDDY'S LABORATORIES, INC.; DR. REDDY'S LABORATORIES, LTD.; GLENMARK GENERICS INC., USA; GLENMARK GENERICS, LTD.; GLENMARK PHARMACEUTICALS, LTD.; LUPIN LTD.; LUPIN PHARMACEUTICALS, INC.; MYLAN PHARMACEUTICALS INC.; MYLAN, INC.; ORCHID CHEMICALS & PHARMACEUTICALS, LTD.; ORCHID HEALTHCARE; ORGENUS PHARMA INC.; ROXANE LABORATORIES, INC.; SEPRACOR INC.; SUN PHARMA GLOBAL INC.; SUN PHARMACEUTICAL INDUSTRIES INC.; SUN PHARMACEUTICAL INDUSTRIES LTD.; SUNOVION PHARMACEUTICALS INC.; TEVA PHARMACEUTICAL INDUSTRIES, LTD.; TEVA PHARMACEUTICALS USA, INC.; WOCKHARDT LTD.; WOCKHARDT USA LLC; WOCKHARDT USA, INC.
Patents 6,319,926; 6,444,673; 6,864,257; 7,381,724
Attorneys ALLYN ZISSEL LITE; ARNOLD B. CALMANN; BRUCE D. RADIN; CHARLES MICHAEL LIZZA; DMITRY V. SHELHOFF; EDWARD DAVID PERGAMENT; ERIC W. DITTMANN; ERICA SUSAN HELMS; FRANK D RODRIGUEZ; GERI L. ALBIN; GERI LAUREN ALBIN; GREGORY ROBERT HAWORTH; JAMES E. CECCHI; JAMES S. RICHTER; JASON TODD CHRISTIANSEN; JEFFREY A. COHEN; JEFFREY I. KAPLAN; JEFFREY S. SOOS; JONATHAN MICHAEL DOLOFF; KAREN A. CONFOY; LOUIS HARRY WEINSTEIN; MARK S. OLINSKY; MAYRA VELEZ TARANTINO; MELISSA E. FLAX; MICHAEL E. PATUNAS; THEODORA T. MCCORMICK; WILLIAM C. BATON
Firms Sills Cummis & Gross
Link to Docket External link to docket
Small Molecule Drugs cited in SUNOVION PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for SUNOVION PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2009)

Date Filed Document No. Description Snippet Link To Document
2009-03-20 1 Complaint United States Patent No. 6,864,257 (“the ’257 patent”), United States Patent No. 6,319,926 (“the ’926 patent…Pysychophavmacol 1990; 5 ( Suppl 2): 95-104. No. 6,319,926, which is a continuation of application No. … as chiral-phase 29, 1998, now U.S. Pat. No. 6,319,926, which is a continu- chromatography, resolution… US 6,319,926 ~1 Cotrel et al. … US 6,319,926 B1 External link to document
2009-06-12 112 Answer to Counterclaim unenforceability of United States Patent No. 6,444,673 (“the ’673 patent”) under 35 U.S.C. § 271(e)(5)…Declaratory Judgment of Invalidity, United States Patent No. 6,444,673) 18. Wockhardt repeats and …Judgment of Non-Infringement, United States Patent No. 6,444,673) 22. Wockhardt repeats and …argument of patentability. Moreover, information is material to patentability if a reasonable patent examiner… issuance of the ’673 patent, that the claims of the ’673 patent were patentable because the dextrorotatory External link to document
2009-06-18 119 Stipulation and Order expiration of U.S. Patent Nos. 6,319,926 (“the ‘926 patent”), 6,444,673 (“the ‘6'?3 patent”), 6,864,2576,864,257 (“the ‘25? patent”) end '?,381,72-4 {“the ‘724 patent”)` WHEREAS, Plaintiff Sepracor inc. (“Sepracor…2009 26 June 2013 2:09-cv-01302-SDW-MF Patent None District Court, D. New Jersey External link to document
2009-07-20 140 Answer to Amended Complaint United States Patent Nos. 6,444,673 (“the ‘673 patent”), 6,319,926 (“the ‘926 patent”), 6,863,257 (…Declaratory Judgment of Invalidity, United States Patent No. 6,319,926) 26. Wockhardt repeats and…Judgment of Non-Infringement, United States Patent No. 6,319,926) 30. Wockhardt repeats and…argument of patentability. Moreover, information is material to patentability if a reasonable patent examiner…the Orange Book patents, that the claims of the Orange Book patents were patentable because the dextrorotatory External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Merck
Dow
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.